[Antiviral activity of some 5-arylethynyl 2'-deoxyuridine derivatives]. 2003

V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
Ivanovsky Institute of Virology, Russian Academy of Medical Sciences, ul. Gamalei 16, Moscow, 123098 Russia.

5-(3-Perylenylethynyl)-2'-deoxyuridine was prepared by cross-linking 5-iodo-2'-deoxyuridine derivatives with 3-ethynylperylene followed by deprotection. 5-(1-Perylenylethynyl)-, 5-(3-perylenylethynyl)-, and 5-[4-(2-benzoxazolyl)phenylethynyl]-2'-deoxyuridine were found to inhibit in Vero cells the replication of type 1 herpes simplex virus and its drug-resistant strains.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D010569 Perylene A 20-carbon dibenz(de,kl)anthracene that can be viewed as a naphthalene fused to a phenalene or as dinaphthalene. It is used as fluorescent lipid probe in the cytochemistry of membranes and is a polycyclic hydrocarbon pollutant in soil and water. Derivatives may be carcinogenic. Perilene,Peri-Dinaphthalene,Peri Dinaphthalene
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002625 Chemistry, Organic The study of the structure, preparation, properties, and reactions of carbon compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Organic Chemistry
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D003857 Deoxyuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. (beta 1-(2-Deoxyribopyranosyl))thymidine
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
January 2005, Bioorganicheskaia khimiia,
V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
April 1986, Archiv der Pharmazie,
V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
February 1978, Journal of medicinal chemistry,
V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
October 1984, Archiv der Pharmazie,
V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
November 1965, Il Farmaco; edizione scientifica,
V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
May 1980, Journal of medicinal chemistry,
V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
November 1979, Biochemical pharmacology,
V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
April 1981, Journal of medicinal chemistry,
V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
May 1978, Molecular pharmacology,
V L Andronova, and M V Skorobogatyĭ, and E V Manasova, and Iu A Berlin, and V A Korshun, and G A Galegov
September 2001, Antiviral chemistry & chemotherapy,
Copied contents to your clipboard!